![Konstantin Bloch](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Konstantin Bloch
Corporate Officer/Principal en Felsenstein Medical Research Center .
Cargos activos de Konstantin Bloch
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Felsenstein Medical Research Center | Corporate Officer/Principal | - | - |
Historial de carrera de Konstantin Bloch
Antiguos cargos conocidos de Konstantin Bloch.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Tel-Aviv University
![]() Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | Corporate Officer/Principal | - | - |
Beta-O2 Technologies Ltd.
![]() Beta-O2 Technologies Ltd. Medical SpecialtiesHealth Technology Beta-O2 Technologies Ltd. develops implantable bio-artificial pancreas devices. It offers BAir, a bio-artificial pancreas that provides a viable environment for islets of Langerhans to thrive and provide the body with insulin on demand. The company was founded by Pnina Vardi, Konstantin Bloch, and Yossi Gross in 2004 and is headquartered in Rosh-Haayin, Israel. | Fundador | 01/01/2004 | - |
Formación de Konstantin Bloch.
Russian Academy of Sciences | Doctorate Degree |
Kharkiv National University | Undergraduate Degree |
Estadísticas
Internacional
Israel | 4 |
Rusia | 2 |
Ucrania | 2 |
Operativa
Corporate Officer/Principal | 2 |
Founder | 1 |
Undergraduate Degree | 1 |
Sectorial
Consumer Services | 4 |
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Beta-O2 Technologies Ltd.
![]() Beta-O2 Technologies Ltd. Medical SpecialtiesHealth Technology Beta-O2 Technologies Ltd. develops implantable bio-artificial pancreas devices. It offers BAir, a bio-artificial pancreas that provides a viable environment for islets of Langerhans to thrive and provide the body with insulin on demand. The company was founded by Pnina Vardi, Konstantin Bloch, and Yossi Gross in 2004 and is headquartered in Rosh-Haayin, Israel. | Health Technology |
Felsenstein Medical Research Center |
- Bolsa de valores
- Insiders
- Konstantin Bloch
- Experiencia